Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction
Aim. In order to study the possibilities of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction recent researches on this problem were reviewed. The literatu...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2015-12-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/57363/54624 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849413136026697728 |
|---|---|
| author | V. V. Syvolap L. V. Lukashenko S. P. Zhemanyuk M. P. Gerasko L. V. Franskyavichene |
| author_facet | V. V. Syvolap L. V. Lukashenko S. P. Zhemanyuk M. P. Gerasko L. V. Franskyavichene |
| author_sort | V. V. Syvolap |
| collection | DOAJ |
| description | Aim. In order to study the possibilities of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction recent researches on this problem were reviewed. The literature data and the results of multicenter randomized controlled trials (RCTs), which will expand not only the understanding of the mechanisms of action of aldosterone receptor antagonists, but also new areas of their application in clinical practice, were analyzed.
Conclusions. Randomized studies have shown that the efficiency of the selective aldosterone antagonist eplerenone has advantages over spironolactone in the improvement of prognosis in post-MI patients with LV systolic dysfunction and/or clinical signs of heart failure. |
| format | Article |
| id | doaj-art-5a4b9576c1024d3e923971a8fb3627cf |
| institution | Kabale University |
| issn | 2306-4145 2310-1210 |
| language | English |
| publishDate | 2015-12-01 |
| publisher | Zaporizhzhia State Medical and Pharmaceutical University |
| record_format | Article |
| series | Zaporožskij Medicinskij Žurnal |
| spelling | doaj-art-5a4b9576c1024d3e923971a8fb3627cf2025-08-20T03:34:13ZengZaporizhzhia State Medical and Pharmaceutical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102015-12-0167480http://dx.doi.org/10.14739/2310-1210.2015.6.57363Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fractionV. V. SyvolapL. V. LukashenkoS. P. ZhemanyukM. P. GeraskoL. V. FranskyavicheneAim. In order to study the possibilities of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction recent researches on this problem were reviewed. The literature data and the results of multicenter randomized controlled trials (RCTs), which will expand not only the understanding of the mechanisms of action of aldosterone receptor antagonists, but also new areas of their application in clinical practice, were analyzed. Conclusions. Randomized studies have shown that the efficiency of the selective aldosterone antagonist eplerenone has advantages over spironolactone in the improvement of prognosis in post-MI patients with LV systolic dysfunction and/or clinical signs of heart failure.http://zmj.zsmu.edu.ua/article/view/57363/54624Myocardial InfarctionAcute DiseaseRandomized Controlled Trials as TopicAldosterone |
| spellingShingle | V. V. Syvolap L. V. Lukashenko S. P. Zhemanyuk M. P. Gerasko L. V. Franskyavichene Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction Zaporožskij Medicinskij Žurnal Myocardial Infarction Acute Disease Randomized Controlled Trials as Topic Aldosterone |
| title | Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction |
| title_full | Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction |
| title_fullStr | Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction |
| title_full_unstemmed | Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction |
| title_short | Features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with ST elevation without chronic heart failure and post-MI chronic heart failure with low ejection fraction |
| title_sort | features of aldosterone antagonists in the treatment of patients with acute myocardial infarction with st elevation without chronic heart failure and post mi chronic heart failure with low ejection fraction |
| topic | Myocardial Infarction Acute Disease Randomized Controlled Trials as Topic Aldosterone |
| url | http://zmj.zsmu.edu.ua/article/view/57363/54624 |
| work_keys_str_mv | AT vvsyvolap featuresofaldosteroneantagonistsinthetreatmentofpatientswithacutemyocardialinfarctionwithstelevationwithoutchronicheartfailureandpostmichronicheartfailurewithlowejectionfraction AT lvlukashenko featuresofaldosteroneantagonistsinthetreatmentofpatientswithacutemyocardialinfarctionwithstelevationwithoutchronicheartfailureandpostmichronicheartfailurewithlowejectionfraction AT spzhemanyuk featuresofaldosteroneantagonistsinthetreatmentofpatientswithacutemyocardialinfarctionwithstelevationwithoutchronicheartfailureandpostmichronicheartfailurewithlowejectionfraction AT mpgerasko featuresofaldosteroneantagonistsinthetreatmentofpatientswithacutemyocardialinfarctionwithstelevationwithoutchronicheartfailureandpostmichronicheartfailurewithlowejectionfraction AT lvfranskyavichene featuresofaldosteroneantagonistsinthetreatmentofpatientswithacutemyocardialinfarctionwithstelevationwithoutchronicheartfailureandpostmichronicheartfailurewithlowejectionfraction |